• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: The Geriatrician, the Primary Care Physician, Aducanumab and the FDA Decision: From Frustration to New Hope.

作者信息

Vellas B J

机构信息

Bruno J Vellas, Gerontopole and Alzheimer's Disease Research and Clinical Center, INSERM UMR 1295 , Toulouse University Hospital, France,

出版信息

J Nutr Health Aging. 2021;25(7):821-823. doi: 10.1007/s12603-021-1657-8.

DOI:10.1007/s12603-021-1657-8
PMID:34409960
Abstract
摘要

相似文献

1
Editorial: The Geriatrician, the Primary Care Physician, Aducanumab and the FDA Decision: From Frustration to New Hope.社论：老年病科医生、初级保健医生、阿杜卡单抗与美国食品药品监督管理局的决定：从挫败到新希望
J Nutr Health Aging. 2021;25(7):821-823. doi: 10.1007/s12603-021-1657-8.
2
Unveiling Aducanumab's safety profile: A comprehensive pharmacovigilance analysis.揭示阿杜卡奴单抗的安全性概况：一项全面的药物警戒分析。
PLoS One. 2025 Jul 14;20(7):e0328076. doi: 10.1371/journal.pone.0328076. eCollection 2025.
3
A bibliometric analysis of the current research status and hotspots regarding Aducanumab treatment for Alzheimer's disease.关于阿杜卡奴单抗治疗阿尔茨海默病的当前研究现状和热点的文献计量分析
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 10. doi: 10.1007/s00210-025-04448-6.
4
Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer's disease: A systematic review and network meta-analysis.在轻度认知障碍和阿尔茨海默病患者中，比较 donanemab、lecanemab、aducanumab 和锂对认知功能的疗效、耐受性和可接受性：一项系统评价和网络荟萃分析。
Ageing Res Rev. 2024 Feb;94:102203. doi: 10.1016/j.arr.2024.102203. Epub 2024 Jan 20.
5
Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease: A Systematic Review and Network Meta-Analysis.多奈单抗、莱卡奈单抗、阿杜卡单抗、褪黑素及有氧运动对轻度认知障碍和轻度阿尔茨海默病认知功能短期影响的疗效、耐受性及可接受性比较：一项系统评价与网状Meta分析
J Alzheimers Dis. 2024;98(3):825-835. doi: 10.3233/JAD-230911.
6
Comparative efficacy of lithium and aducanumab for cognitive decline in patients with mild cognitive impairment or Alzheimer's disease: A systematic review and network meta-analysis.锂剂与 aducanumab 治疗轻度认知障碍或阿尔茨海默病患者认知衰退的疗效比较：系统评价和网络荟萃分析。
Ageing Res Rev. 2022 Nov;81:101709. doi: 10.1016/j.arr.2022.101709. Epub 2022 Aug 9.
7
Aducanumab for the treatment of Alzheimer's disease: a systematic review.阿杜卡奴单抗治疗阿尔茨海默病的系统评价。
Psychogeriatrics. 2023 May;23(3):512-522. doi: 10.1111/psyg.12944. Epub 2023 Feb 12.
8
The FDA-approved anti-amyloid-β monoclonal antibodies for the treatment of Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials.经 FDA 批准用于治疗阿尔茨海默病的抗淀粉样蛋白-β单克隆抗体：一项随机对照试验的系统评价和荟萃分析。
Eur J Med Res. 2023 Nov 28;28(1):544. doi: 10.1186/s40001-023-01512-w.
9
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
10
The Increasing Use of Clinical Outcome Assessments in US Food and Drug Administration Labels and the German Gemeinsamer Bundesausschuss, National Institute for Health and Care Excellence, and the French Haute Autorité de Santé Assessments From 2012 to 2022.
Value Health. 2025 Aug;28(8):1195-1203. doi: 10.1016/j.jval.2025.05.002. Epub 2025 May 21.

引用本文的文献

1
Patients with geriatric syndromes and anti-amyloid therapies: lack of consideration? An exploratory analysis of the literature.老年综合征患者与抗淀粉样蛋白疗法：是否未被考虑？文献的探索性分析
Front Aging Neurosci. 2023 Oct 10;15:1256968. doi: 10.3389/fnagi.2023.1256968. eCollection 2023.
2
Strategies for translating proteomics discoveries into drug discovery for dementia.将蛋白质组学发现转化为痴呆症药物发现的策略。
Neural Regen Res. 2024 Jan;19(1):132-139. doi: 10.4103/1673-5374.373681.
3
Imaging blood-brain barrier dysfunction: A state-of-the-art review from a clinical perspective.

本文引用的文献

1
New Hope for Alzheimer's Disease.阿尔茨海默病的新希望。
J Prev Alzheimers Dis. 2021;8(3):238-239. doi: 10.14283/jpad.2021.26.
2
Donanemab in Early Alzheimer's Disease.多奈单抗用于早期阿尔茨海默病
N Engl J Med. 2021 May 6;384(18):1691-1704. doi: 10.1056/NEJMoa2100708. Epub 2021 Mar 13.
3
Intrinsic Capacitiy Monitoring by Digital Biomarkers in Integrated Care for Older People (ICOPE).数字生物标志物在老年人综合护理中的内在能力监测（ICOPE）。
成像血脑屏障功能障碍：从临床角度的最新综述
Front Aging Neurosci. 2023 Apr 17;15:1132077. doi: 10.3389/fnagi.2023.1132077. eCollection 2023.
J Frailty Aging. 2021;10(2):132-138. doi: 10.14283/jfa.2020.51.
4
Framework Implementation of the INSPIRE ICOPE-CARE Program in Collaboration with the World Health Organization (WHO) in the Occitania Region.与世界卫生组织（WHO）合作在奥克西塔尼地区实施 INSPIRE ICOPE-CARE 计划的框架。
J Frailty Aging. 2021;10(2):103-109. doi: 10.14283/jfa.2020.26.
5
Editorial: Integrated Care for Older People (ICOPE): From Guidelines to Demonstrating Feasibility.社论：老年人综合照护（ICOPE）：从指南到可行性论证
J Frailty Aging. 2021;10(2):84-85. doi: 10.14283/jfa.2020.40.
6
Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease.血浆磷酸化 Tau217 水平与早期阿尔茨海默病 Tau 正电子发射断层扫描的相关性。
JAMA Neurol. 2021 Feb 1;78(2):149-156. doi: 10.1001/jamaneurol.2020.4201.
7
Screening for and Managing the Person with Frailty in Primary Care: ICFSR Consensus Guidelines.基层医疗中衰弱患者的筛查与管理：ICFSR 共识指南
J Nutr Health Aging. 2020;24(9):920-927. doi: 10.1007/s12603-020-1492-3.
8
Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative.阿尔茨海默病神经影像学倡议中血浆磷酸化 tau181 的诊断性能和临床进展预测。
Mol Psychiatry. 2021 Feb;26(2):429-442. doi: 10.1038/s41380-020-00923-z. Epub 2020 Oct 26.
9
The Future of Anti-Amyloid Trials.抗淀粉样蛋白治疗临床试验的未来。
J Prev Alzheimers Dis. 2020;7(3):146-151. doi: 10.14283/jpad.2020.24.
10
Integrated Care for Older People and the Implementation in the INSPIRE Care Cohort.老年人综合护理以及在 INSPIRE 护理队列中的实施。
J Prev Alzheimers Dis. 2020;7(2):70-74. doi: 10.14283/jpad.2020.8.